Literature DB >> 1517590

Monocyte proliferation in a cytokine-free, serum-free system.

S Bennett1, S B Por, E R Stanley, S N Breit.   

Abstract

The aim of this study was to establish a cytokine-free, serum-free system which would enable the long-term survival and proliferation of human peripheral blood monocytes. Monocytes were isolated from peripheral blood mononuclear cells (PBMC) by adherence to untreated plastic petri dishes and maintained up to 6 weeks in serum-free medium (SFM) consisting of IMEM, insulin, transferrin, sodium selenite and BSA. Maximal cell proliferation occurred during the first 2 weeks of culture and corresponded to the appearance of large numbers of pure, nonadherent culture-derived macrophages. Monocyte maturation was characterised by the modulation of specific cell surface antigens. The percentage of cells staining for the transferrin receptor increased with time, whereas the percentages of cells expressing CD11b, CD11c and HLA-DR remained greater than 60% for the 15 days studied. The mean fluorescent intensities (MFI) of all these antibodies increased significantly with time. The only differences found between the adherent and nonadherent cells, using the above antibodies, were with the MFI for CD11b and CD11c. In both cases, the intensity of staining was significantly greater in the adherent cells. Estimation of cytokine production by cells maintained for 5 weeks in SFM found that they constitutively produced large amounts of macrophage colony-stimulating factor (M-CSF) in the absence of any exogenous stimuli. These cells were also found to secrete high levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) during the 1st week and granulocyte macrophage colony-stimulating factor (GM-CSF) during the 3rd week. However, the addition of exogenous GM-CSF (5 U/ml, S5) was found to significantly inhibit monocyte proliferation up to 17 days. This is the first report of proliferation associated with long-term survival of culture derived macrophages in a serum-free, cytokine-free system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517590     DOI: 10.1016/0022-1759(92)90323-l

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

Authors:  M R Bootcov; A R Bauskin; S M Valenzuela; A G Moore; M Bansal; X Y He; H P Zhang; M Donnellan; S Mahler; K Pryor; B J Walsh; R C Nicholson; W D Fairlie; S B Por; J M Robbins; S N Breit
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Dysregulation in microRNA expression in peripheral blood mononuclear cells of sepsis patients is associated with immunopathology.

Authors:  Juhua Zhou; Hina Chaudhry; Yin Zhong; Mir Mustafa Ali; Linda A Perkins; William B Owens; Juan E Morales; Franklin R McGuire; Elizabeth E Zumbrun; Jiajia Zhang; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Cytokine       Date:  2014-09-29       Impact factor: 3.861

3.  A potassium ion channel is involved in cytokine production by activated human macrophages.

Authors:  M R Qiu; T J Campbell; S N Breit
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

4.  Human macrophages contain a stretch-sensitive potassium channel that is activated by adherence and cytokines.

Authors:  D K Martin; M R Bootcov; T J Campbell; P W French; S N Breit
Journal:  J Membr Biol       Date:  1995-10       Impact factor: 1.843

5.  Substance P augments tumor necrosis factor release in human monocyte-derived macrophages.

Authors:  H R Lee; W Z Ho; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

6.  Phenotypic and functional changes in blood monocytes following adherence to endothelium.

Authors:  Colin Tso; Kerry-Anne Rye; Philip Barter
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 7.  Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment.

Authors:  Emily L Hopewell; Cheryl Cox
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-15       Impact factor: 6.698

8.  The proliferative human monocyte subpopulation contains osteoclast precursors.

Authors:  Roya Lari; Peter D Kitchener; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2009-02-17       Impact factor: 5.156

9.  Fibronectin binding is required for acquisition of mesenchymal/endothelial differentiation potential in human circulating monocytes.

Authors:  Noriyuki Seta; Yuka Okazaki; Keisuke Izumi; Hiroshi Miyazaki; Takashi Kato; Masataka Kuwana
Journal:  Clin Dev Immunol       Date:  2012-11-01

10.  Inflammatory status of transmigrating primary rat monocytes in a novel perfusion model simulating blood flow.

Authors:  Lindsay A Hohsfield; Christoph G Ammann; Christian Humpel
Journal:  J Neuroimmunol       Date:  2013-03-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.